American Heart Association
New Insights in Lipids and lipid lowering therapies
Abstract Oral Session
S102BC
Nov 18th , 09:45 AM - 11:00 AM
10 : 00 AM
The Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results from the ODYSSEY OUTCOMES Trial
Geba Gregory, Mohammadi Kusha, Damask Amy, Paulding Charles, Lotta Luca, Hindy George, Pordy Robert, Manvelian Garen, Shapiro Michael, Bittner Vera, Bhatt Deepak, Szarek Michael, Schwartz Gregory, Steg Philippe, Fazio Sergio
Final Pr. ID: 4140467
Authors: Geba Gregory, Mohammadi Kusha, Damask Amy, Paulding Charles, Lotta Luca, Hindy George, Pordy Robert, Manvelian Garen, Shapiro Michael, Bittner Vera, Bhatt Deepak, Szarek Michael, Schwartz Gregory, Steg Philippe, Fazio Sergio
Keywords: Clinical trials , LDL , Lipids , PCSK9 , Cardiovascular Risk
Jiao Jingjing, Zhang Yu, Zhuang Pan, Liu Xiaohui, Wan Xuzhi
Final Pr. ID: 4142898
Authors: Jiao Jingjing, Zhang Yu, Zhuang Pan, Liu Xiaohui, Wan Xuzhi
Keywords: Carotid arteries , Genes , environment , and lifestyle interactions , Diabetes Mellitus , Atherogenic , Cholesterol
10 : 30 AM
Lipoprotein (a), Triglyceride-Glucose Index and Incident Atherosclerotic Cardiovascular Disease (ASCVD): Analysis of the UK Biobank
Kazibwe Richard, Schaich Christopher, Chevli Parag, Kingsley Jeffrey, Rikhi Rishi, Ahmad Muhammad, Mirzai Saeid, Namutebi Juliana, Mehta Anurag, Bhatia Harpreet, Michos Erin, Shapiro Michael
Final Pr. ID: 4138332
Authors: Kazibwe Richard, Schaich Christopher, Chevli Parag, Kingsley Jeffrey, Rikhi Rishi, Ahmad Muhammad, Mirzai Saeid, Namutebi Juliana, Mehta Anurag, Bhatia Harpreet, Michos Erin, Shapiro Michael
Keywords: Lipoproteins , Cardiovascular disease , Insulin resistance , Cardiovascular Risk
10 : 45 AM
Plozasiran and Triglyceride Levels in Hypertriglyceridemia: Long-Term Efficacy and Safety Data From Subjects in an Open-Label Extension Trial
Ballantyne Christie, Watts Gerald, Rosenson Robert, Vasas Szilárd, Pall Denes, Clifton Peter, Nicholls Stephen, Azizad Masoud, Fu Ran, Muhsin Maan, Melquist Stacey, Hellawell Jennifer, Gaudet Daniel
Final Pr. ID: 4139852
Authors: Ballantyne Christie, Watts Gerald, Rosenson Robert, Vasas Szilárd, Pall Denes, Clifton Peter, Nicholls Stephen, Azizad Masoud, Fu Ran, Muhsin Maan, Melquist Stacey, Hellawell Jennifer, Gaudet Daniel
Keywords: Atherosclerosis , Pancreatitis , Apolipoproteins , Triglycerides , Polygenic Risk
10 : 30 AM
Lipoprotein (a), Triglyceride-Glucose Index and Incident Atherosclerotic Cardiovascular Disease (ASCVD): Analysis of the UK Biobank
Kazibwe Richard, Schaich Christopher, Chevli Parag, Kingsley Jeffrey, Rikhi Rishi, Ahmad Muhammad, Mirzai Saeid, Namutebi Juliana, Mehta Anurag, Bhatia Harpreet, Michos Erin, Shapiro Michael
Final Pr. ID: 4138332
Authors: Kazibwe Richard, Schaich Christopher, Chevli Parag, Kingsley Jeffrey, Rikhi Rishi, Ahmad Muhammad, Mirzai Saeid, Namutebi Juliana, Mehta Anurag, Bhatia Harpreet, Michos Erin, Shapiro Michael
Keywords: Lipoproteins , Cardiovascular disease , Insulin resistance , Cardiovascular Risk
Jiao Jingjing, Zhang Yu, Zhuang Pan, Liu Xiaohui, Wan Xuzhi
Final Pr. ID: 4142898
Authors: Jiao Jingjing, Zhang Yu, Zhuang Pan, Liu Xiaohui, Wan Xuzhi
Keywords: Carotid arteries , Genes , environment , and lifestyle interactions , Diabetes Mellitus , Atherogenic , Cholesterol
10 : 45 AM
Plozasiran and Triglyceride Levels in Hypertriglyceridemia: Long-Term Efficacy and Safety Data From Subjects in an Open-Label Extension Trial
Ballantyne Christie, Watts Gerald, Rosenson Robert, Vasas Szilárd, Pall Denes, Clifton Peter, Nicholls Stephen, Azizad Masoud, Fu Ran, Muhsin Maan, Melquist Stacey, Hellawell Jennifer, Gaudet Daniel
Final Pr. ID: 4139852
Authors: Ballantyne Christie, Watts Gerald, Rosenson Robert, Vasas Szilárd, Pall Denes, Clifton Peter, Nicholls Stephen, Azizad Masoud, Fu Ran, Muhsin Maan, Melquist Stacey, Hellawell Jennifer, Gaudet Daniel
Keywords: Atherosclerosis , Pancreatitis , Apolipoproteins , Triglycerides , Polygenic Risk
10 : 00 AM
The Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results from the ODYSSEY OUTCOMES Trial
Geba Gregory, Mohammadi Kusha, Damask Amy, Paulding Charles, Lotta Luca, Hindy George, Pordy Robert, Manvelian Garen, Shapiro Michael, Bittner Vera, Bhatt Deepak, Szarek Michael, Schwartz Gregory, Steg Philippe, Fazio Sergio
Final Pr. ID: 4140467
Authors: Geba Gregory, Mohammadi Kusha, Damask Amy, Paulding Charles, Lotta Luca, Hindy George, Pordy Robert, Manvelian Garen, Shapiro Michael, Bittner Vera, Bhatt Deepak, Szarek Michael, Schwartz Gregory, Steg Philippe, Fazio Sergio
Keywords: Clinical trials , LDL , Lipids , PCSK9 , Cardiovascular Risk